利用常规纵向实验室数据对妊娠相关血栓性微血管病进行可解释性机器学习预测
Interpretable Machine Learning for Antepartum Prediction of Pregnancy-Associated Thrombotic Microangiopathy Using Routine Longitudinal Laboratory Data
AI总结:
本文通过可解释性机器学习方法,利用常规纵向实验室数据预测妊娠相关血栓性微血管病风险,采用梯度提升算法在测试集上取得高AUC值,发现胱atin C在第6周具有早期监测潜力。
摘要:
背景:妊娠相关血栓性微血管病(P-TMA)罕见但致命。在临床表现前进行早期风险预测仍然具有挑战性,因为相关的实验室异常是微妙的、多维的,且常被常见的生理变化如妊娠血小板减少和妊娠相关蛋白尿所掩盖,因此与良性产科和肾病条件重叠。这种复杂性难以用单变量或规则方法捕捉;然而,机器学习可以从中提取出时间依赖的风险特征。方法:本回顾性研究纳入了300例妊娠病例,包括142例P-TMA病例和158例对照。在排除标识符和非信息性变量后,保留了146个纵向实验室预测因子。参与者被分为训练组(80%)和保留的测试组(20%),使用分层抽样。评估了五种算法:逻辑回归、支持向量机(径向基函数核)、随机森林、额外树和梯度提升。最终模型通过交叉验证的平均AUROC选择,重新拟合于完整训练组,并在保留的测试组中评估一次。可解释性分析检查了全局特征重要性和领先预测因子的分布模式。结果:梯度提升在训练组中通过交叉验证预选。模型在保留的测试组中实现了AUROC为0.872(95%置信区间:0.769-0.952)和AUPRC为0.883(95%置信区间:0.780-0.959),灵敏度为0.750,特异性为0.812。结论:常规护理中获得的纵向临床实验室测试包含有关P-TMA风险的信息和临床合理的信号。值得注意的是,第6周的胱氨酸C显示出作为早期监测指标的潜力。
英文摘要:
Background: Pregnancy-associated thrombotic microangiopathy (P-TMA) is rare but life-threatening. Early risk prediction before overt clinical presentation remains challenging, as the associated laboratory abnormalities are subtle, multidimensional, and frequently masked by common physiological changes such as gestational thrombocytopenia and pregnancy-related proteinuria, thus overlapping heavily with benign obstetric and renal conditions. This complexity is poorly captured by univariate or rule-based approaches; however, it is addressable by machine learning, which can extract latent, time-dependent risk signatures from longitudinal clinical tests. Methods: This retrospective study included 300 pregnancies comprising 142 P-TMA cases and 158 controls. After exclusion of identifiers and non-informative variables, 146 longitudinal laboratory predictors were retained. Participants were divided into a training cohort (80%) and a held-out test cohort (20%) using stratified sampling. Five algorithms were evaluated: logistic regression, support vector machine with radial basis function kernel, random forest, extra trees, and gradient boosting. The final model was selected by mean cross-validated AUROC, refitted on the full training cohort, and evaluated once in the held-out test cohort. Interpretability analyses examined global feature importance and distributional patterns of leading predictors. Results: Gradient boosting was prespecified by cross-validation in the training cohort. The model achieved an AUROC of 0.872 (95% CI: 0.769-0.952) and an AUPRC of 0.883 (95% CI: 0.780-0.959) in a held-out test cohort, with sensitivity of 0.750 and specificity of 0.812. Conclusions: Longitudinal clinical laboratory tests obtained during routine care contained informative and clinically plausible signals for P-TMA risk. Notably, cystatin C at week 6 showed promise as an early monitoring indicator.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。